Children’s Book Week is the perfect excuse to dive into a good story and get kids excited about reading. Whether they’re ...

Last month, the National Security Commission on Emerging Biotechnology (NSCEB), chaired by Senator Todd Young (R-IN), published a report raising the alarm around the United States’ ceded ground in ...

Biology, being the most scoring and significant section of the NEET exam, demands focused attention. To help students make the most of this limited time, we’ve curated the Top 30 Biology ...

No sector is left unchanged by the power of AI and digital modeling, and Biotech is no exception. This is because biology is by far the most “messy” of hard sciences. Chemistry or physics can deal ...

This cutting-edge field represents the convergence of artificial intelligence, sensor technology, and biotechnology. For investors looking beyond the quarterly hype cycle, this emerging sector ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...

Going public via SPAC was a very 2021 thing to do. During the peak of the last bull market, dozens of startups took this quick route to market, merging with publicly traded shell companies, or SPACs, ...

The Lilly-Creyon pact will span “a broad range of diseases," the pair said in a statement, as Lilly buys into the biotech’s so-called “AI-Powered Oligo Engineering Engine.” Creyon debuted ...

Octagon Therapeutics has thrown in the towel. The Novo Nordisk-allied autoimmune disease biotech is winding down after deprioritizing its lead program and running into unresolved biology questions.

China’s WuXi AppTec, which a US legislative commission called the “Huawei equivalent for biotechnology”, has reported a surge in US business despite increased scrutiny from Washington ...

Biotech firm Jade Biosciences Inc. has completed its merger with Aerovate Therapeutics Inc. (Nasdaq:AVTE), in a move that will put the former on the Nasdaq. Jade’s Vancouver-based CEO, Tom ...